Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04469244
Other study ID # 2020PI063
Secondary ID
Status Completed
Phase
First received
Last updated
Start date July 1, 2020
Est. completion date October 20, 2020

Study information

Verified date December 2020
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The evaluation of gliomas in imaging represents a real challenge today, at the initial diagnosis, for therapeutic planning or follow-up treatment of these lesions. There is an urgent need for non-invasive imaging tools to evaluate a glioma throughout its management. At present, the diagnosis of certainty is only obtained through an anatomo-pathological analysis with sampling during an invasive procedure (surgery or biopsy). Magnetic resonance imaging, through perfusion, diffusion imaging or spectroscopy is developing in gliomas. However, it remains time-consuming and is not always available. At the same time, positron emission tomography (PET) with amino acids is an interesting alternative for these brain tumours. Amino acid PET has the advantage of being more specific than the abnormalities detected in MRI and the amino acid radiotracers cross the blood-brain barrier, even if not broken, unlike Gadolinium in MRI. Among these radiotracers, 18F-FDOPA can, among other things, assist in the non-invasive staging of gliomas at initial diagnosis.


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date October 20, 2020
Est. primary completion date August 3, 2020
Accepts healthy volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient having performed a PET/CT examination at 18F-FDOPA for his glioma in the nuclear medicine department of the CHRU de Brabois for which the raw data are available; - Person who received full information on the organization of the research and did not object to the use of these data; - Patients affiliated to a social security scheme Exclusion Criteria: - - Person who received full information on the organization of the research and who objected to the use of the data - Adult person subject to a legal protection measure (guardianship, curatorship, safeguard of justice). - A person of full age who is unable to give consent and who is not subject to a legal protection measure.

Study Design


Related Conditions & MeSH terms

  • Glioma
  • Study on the Use of Radiomics in Gliomas of Initial Disgnosis

Locations

Country Name City State
France CHRU of Nancy VandÅ“uvre-lès-Nancy

Sponsors (1)

Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict the molecular characteristics of gliomas at initial diagnosis. Evaluating the performance of radiomics use in gliomas at initial diagnosis 1 year
Secondary Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict glioma recurrence Assessing the performance of radiomics use in the search for glioma recurrence 1 year
Secondary Diagnostic performance (sensitivity, specificity, accuracy) of parameters extracted from radiomic analysis to predict the response to glioma treatments. Evaluating the performance of the use of radiomics in the follow-up of glioma disease treatments 1 year
Secondary Comparison of dynamic parameters (time to peak, slope, area under curve) obtained with different reconstruction parameters versus dynamic parameters obtained on digital phantom from literature data Optimization of dynamic analysis for the interpretation of the PET/CT examination at 18F-FDOPA 6 months
Secondary Comparison of dynamic parameters (time to peak, slope, area under curve) obtained with different reconstruction parameters versus dynamic parameters obtained on digital phantom from literature data Comparison of diagnostic performance of radiomics, static and dynamic parameters. 1 years